These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. Lister JJ; Greenwald MK; Ledgerwood DM J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598 [TBL] [Abstract][Full Text] [Related]
3. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic. Lister JJ; Brown S; Greenwald MK; Ledgerwood DM Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262 [No Abstract] [Full Text] [Related]
4. A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study. Proctor SL; Copeland AL; Kopak AM; Herschman PL; Polukhina N Exp Clin Psychopharmacol; 2014 Oct; 22(5):424-33. PubMed ID: 25069011 [TBL] [Abstract][Full Text] [Related]
5. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601 [TBL] [Abstract][Full Text] [Related]
6. The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance Treatment. Proctor SL; Herschman PL; Lee R; Kopak AM Subst Use Misuse; 2019; 54(1):97-105. PubMed ID: 30362864 [TBL] [Abstract][Full Text] [Related]
7. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients. Sankey C; Setnik B; Harsanyi Z; Michalko K; Yang Z; Geoffroy P J Opioid Manag; 2016; 12(2):149-59. PubMed ID: 27194200 [TBL] [Abstract][Full Text] [Related]
8. The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Naji L; Dennis BB; Bawor M; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; MacKillop J; Thabane L; Samaan Z Addict Sci Clin Pract; 2017 Mar; 12(1):9. PubMed ID: 28347350 [TBL] [Abstract][Full Text] [Related]
9. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism. Westerberg VS; McCrady BS; Owens M; Guerin P J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182 [TBL] [Abstract][Full Text] [Related]
10. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J; Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082 [TBL] [Abstract][Full Text] [Related]
11. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China. Zhou K; Li H; Wei X; Li X; Zhuang G J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264 [TBL] [Abstract][Full Text] [Related]
12. [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients]. Ortner R; Peternell A; Kraigher D; Schindler S; Topitz A; Fischer G Wien Klin Wochenschr; 2001 Dec; 113(23-24):934-8. PubMed ID: 11802509 [TBL] [Abstract][Full Text] [Related]
14. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis. Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286 [TBL] [Abstract][Full Text] [Related]
15. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Peles E; Schreiber S; Adelson M Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428 [TBL] [Abstract][Full Text] [Related]
16. Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature Discharge. Proctor SL; Birch A; Herschman PL J Addict Med; 2019; 13(2):113-118. PubMed ID: 30199427 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment. Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486 [TBL] [Abstract][Full Text] [Related]
18. Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment. Malik E; Adelson M; Sason A; Schreiber S; Peles E J Dual Diagn; 2019; 15(4):281-290. PubMed ID: 31530109 [No Abstract] [Full Text] [Related]
19. The impact of benzodiazepine use on methadone maintenance treatment outcomes. Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Yin W; Pang L; Cao X; McGoogan JM; Liu M; Zhang C; Li Z; Li J; Rou K Addiction; 2015 Jan; 110 Suppl 1():51-60. PubMed ID: 25533864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]